Tomer Gold

Directeur Technique/Scientifique/R&D chez Dexcel Pharma Technologies Ltd.

52 ans

Health Technology

Consumer Services

Postes actifs de Tomer Gold

Sociétés	Poste	Début	Fin
Dexcel Pharma Technologies Ltd. Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel.	Directeur Technique/Scientifique/R&D	01/01/2011	-

Sociétés	Poste	Début	Fin
CYNAPSUS THERAPEUTICS INC	Directeur/Membre du Conseil	09/05/2013	21/10/2016
CYNAPSUS THERAPEUTICS INC	Independent Dir/Board Member	04/08/2014	21/10/2016

Technion-Israel Institute of Technology

Graduate Degree

Internationale

Israël	3
Canada	2

Opérationnelle

Director/Board Member	1
Independent Dir/Board Member	1
Graduate Degree	1

Sectorielle

Health Technology	3
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Entreprise privées	2
Cynapsus Therapeutics, Inc. Cynapsus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cynapsus Therapeutics, Inc. operated as a pharmaceutical company, which developed an improved dosing formulation of an approved drug used to treat the symptoms of Parkinson's disease. The company was founded by Andrew Williams and David Hill on January 16, 2004 and was headquartered in Toronto, Canada.	Health Technology
Dexcel Pharma Technologies Ltd. Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel.	Health Technology